Robert Chan
Publications by Year
Research Areas
Asthma and respiratory diseases, Sinusitis and nasal conditions, Allergic Rhinitis and Sensitization, Inhalation and Respiratory Drug Delivery, Respiratory and Cough-Related Research
Most-Cited Works
- → Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial(2021)539 cited
- → Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) Trial(2002)260 cited
- → The roles of eosinophils and interleukin‐5 in the pathophysiology of chronic rhinosinusitis with nasal polyps(2022)117 cited
- → Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil count(2022)115 cited
- → From DREAM to REALITI‐A and beyond: Mepolizumab for the treatment of eosinophil‐driven diseases(2021)106 cited
- → Efficacy and safety of the p38 MAPK inhibitor losmapimod for patients with chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial(2013)92 cited
- → A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a novel inhaled αvβ6 integrin inhibitor(2020)79 cited
- → The PRESTO (Prevention of Restenosis with Tranilast and its Outcomes) protocol: A double-blind, placebo-controlled trial(2000)77 cited
- → Design of the Blockade of the Glycoprotein IIb/IIIa Receptor to Avoid Vascular Occlusion (BRAVO) trial(2000)68 cited
- → A new class of bronchodilator improves lung function in COPD: a trial with GSK961081(2013)53 cited